238 related articles for article (PubMed ID: 12483305)
1. Functional polymorphisms in the mineralocorticoid receptor and amirolide-sensitive sodium channel genes in a patient with sporadic pseudohypoaldosteronism.
Arai K; Nakagomi Y; Iketani M; Shimura Y; Amemiya S; Ohyama K; Shibasaki T
Hum Genet; 2003 Jan; 112(1):91-7. PubMed ID: 12483305
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of amiloride-sensitive sodium channel subunits in five sporadic cases of pseudohypoaldosteronism: do they have pathologic potential?
Arai K; Zachman K; Shibasaki T; Chrousos GP
J Clin Endocrinol Metab; 1999 Jul; 84(7):2434-7. PubMed ID: 10404817
[TBL] [Abstract][Full Text] [Related]
3. Novel mutations in epithelial sodium channel (ENaC) subunit genes and phenotypic expression of multisystem pseudohypoaldosteronism.
Edelheit O; Hanukoglu I; Gizewska M; Kandemir N; Tenenbaum-Rakover Y; Yurdakök M; Zajaczek S; Hanukoglu A
Clin Endocrinol (Oxf); 2005 May; 62(5):547-53. PubMed ID: 15853823
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.
Geller DS; Rodriguez-Soriano J; Vallo Boado A; Schifter S; Bayer M; Chang SS; Lifton RP
Nat Genet; 1998 Jul; 19(3):279-81. PubMed ID: 9662404
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid resistance.
Zennaro MC; Lombès M
Trends Endocrinol Metab; 2004 Aug; 15(6):264-70. PubMed ID: 15358279
[TBL] [Abstract][Full Text] [Related]
6. No apparent mineralocorticoid receptor defect in a series of sporadic cases of pseudohypoaldosteronism.
Arai K; Tsigos C; Suzuki Y; Listwak S; Zachman K; Zangeneh F; Rapaport R; Chanoine JP; Chrousos GP
J Clin Endocrinol Metab; 1995 Mar; 80(3):814-7. PubMed ID: 7883835
[TBL] [Abstract][Full Text] [Related]
7. The ENaC channel as the primary determinant of two human diseases: Liddle syndrome and pseudohypoaldosteronism.
Schild L
Nephrologie; 1996; 17(7):395-400. PubMed ID: 8987044
[TBL] [Abstract][Full Text] [Related]
8. Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy.
Arai K; Tsigos C; Suzuki Y; Irony I; Karl M; Listwak S; Chrousos GP
J Clin Endocrinol Metab; 1994 Oct; 79(4):1019-23. PubMed ID: 7962269
[TBL] [Abstract][Full Text] [Related]
9. [Monogenic hypertension].
Bähr V; Oelkers W; Diederich S
Med Klin (Munich); 2003 Apr; 98(4):208-17. PubMed ID: 12715144
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular features of type 1 pseudohypoaldosteronism.
Riepe FG
Horm Res; 2009; 72(1):1-9. PubMed ID: 19571553
[TBL] [Abstract][Full Text] [Related]
11. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1.
Chang SS; Grunder S; Hanukoglu A; Rösler A; Mathew PM; Hanukoglu I; Schild L; Lu Y; Shimkets RA; Nelson-Williams C; Rossier BC; Lifton RP
Nat Genet; 1996 Mar; 12(3):248-53. PubMed ID: 8589714
[TBL] [Abstract][Full Text] [Related]
12. [Genetic disorders caused by gain or loss of function of the mineralocorticoid receptor].
Arai K; Shibasaki T
Nihon Rinsho; 2002 Feb; 60(2):361-6. PubMed ID: 11857927
[TBL] [Abstract][Full Text] [Related]
13. [Pseudohypoaldosteronism].
Arai K; Naruse K; Tanabe A; Naruse M; Demura H
Nihon Rinsho; 1996 Mar; 54(3):812-8. PubMed ID: 8904242
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneity.
Riepe FG; Krone N; Morlot M; Ludwig M; Sippell WG; Partsch CJ
J Clin Endocrinol Metab; 2003 Apr; 88(4):1683-6. PubMed ID: 12679457
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone resistance: structural and functional considerations and new perspectives.
Zennaro MC; Hubert EL; Fernandes-Rosa FL
Mol Cell Endocrinol; 2012 Mar; 350(2):206-15. PubMed ID: 21664233
[TBL] [Abstract][Full Text] [Related]
16. A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families.
Strautnieks SS; Thompson RJ; Gardiner RM; Chung E
Nat Genet; 1996 Jun; 13(2):248-50. PubMed ID: 8640238
[TBL] [Abstract][Full Text] [Related]
17. No evidence of hearing loss in pseudohypoaldosteronism type 1 patients.
Peters TA; Levtchenko E; Cremers CW; Curfs JH; Monnens LA
Acta Otolaryngol; 2006 Mar; 126(3):237-9. PubMed ID: 16618647
[TBL] [Abstract][Full Text] [Related]
18. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.
Pujo L; Fagart J; Gary F; Papadimitriou DT; Claës A; Jeunemaître X; Zennaro MC
Hum Mutat; 2007 Jan; 28(1):33-40. PubMed ID: 16972228
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation of the epithelial Na+ channel causes type 1 pseudohypoaldosteronism.
Bonny O; Knoers N; Monnens L; Rossier BC
Pediatr Nephrol; 2002 Oct; 17(10):804-8. PubMed ID: 12376807
[TBL] [Abstract][Full Text] [Related]
20. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.
Sartorato P; Khaldi Y; Lapeyraque AL; Armanini D; Kuhnle U; Salomon R; Caprio M; Viengchareun S; Lombès M; Zennaro MC
Mol Cell Endocrinol; 2004 Mar; 217(1-2):119-25. PubMed ID: 15134810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
